Patents by Inventor Yannick Rose

Yannick Rose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130040892
    Abstract: A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods.
    Type: Application
    Filed: February 11, 2011
    Publication date: February 14, 2013
    Applicant: PHARMASCIENCE INC.
    Inventors: Alain Laurent, Melanie Proulx, Yannick Rose, Irina Denissova, Kenza Dairi, Scott Jarvis, James B. Jaquith
  • Publication number: 20110171171
    Abstract: A compound of Formula 1.1A: 1.1A or salt thereof, as well as methods of making compounds of Formula 1.1A, methods of using compounds of Formula 1.1A to treat proliferative disorders such as cancer, and related compounds, composition, and methods.
    Type: Application
    Filed: June 26, 2009
    Publication date: July 14, 2011
    Applicant: Aegera Therapeutics, Inc.
    Inventors: Alain Laurent, Melanie Proulx, Yannick Rose, James B. Jaquith, Stephen Morris
  • Publication number: 20100203012
    Abstract: Disclosed herein is a compound of Formula 1: or a salt thereof, in which R1, R1a, R100, R100a, R2, R200, R3, R300, A, A1, Q, Q1 and BG are as defined herein. Also disclosed is the use of the compounds of Formula 1 to treat disorders of dysregulated apoptosis, such as cancer and cellular proliferative disorders.
    Type: Application
    Filed: May 30, 2008
    Publication date: August 12, 2010
    Applicant: Aegera Therapeutics, Inc.
    Inventors: Alain Laurent, Patrick Bureau, James Jaquith, John Gillard, Yannick Rose